跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACCEL-DULOXETINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACCEL-DULOXETINE
Authorized
STANDARD
ACCEL-DULOXETINE
accel pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
42753b2a3e059b81
Company
accel pharma inc
Type
Standard
Approval Details
Approval Id
42753b2a3e059b81
Drug Approval Canada Name
ACCEL-DULOXETINE
Product Name
ACCEL-DULOXETINE
Status
Marketed
Status Date
2022-04-04
Original Market Date
2022-04-04
Din
02522888
Drug Class
Human
Dosage Form
Capsule (Delayed Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.16
Atc Original
N06AX21 DULOXETINE
Atc Name
n 06 ax 21
Aig Number
0152350002
Company Name
accel pharma inc
Company Address
119 Labrosse Ave, Pointe Claire, Quebec, Canada, H9R 1A3
Active Ingredients
DULOXETINE (DULOXETINE HYDROCHLORIDE)
60 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
42753b2a3e059b81
Type
Standard
Back to Health Canada Approvals